March 25th 2023
A look back on what happened in optometry during the week of March 20-March 24.
Eye care therapies on the move: What’s in the pipeline
September 16th 2022Melissa Barnett, OD, from the University of California, Davis Eye Center, Sacramento and Davis, CA, described new strategies, technologies, and drug classes to treat chronic conditions that include myopia, Demodex infestation, meibomian gland dysfunction, glaucoma drug delivery, advancements in corneal and cataract surgeries, and presbyopia
Visus Therapeutics, Zhaoke Ophthalmology partner on presbyopia drops in Asian markets
May 12th 2022Companies are entering an exclusive licensing agreement for the development and commercialization of Brimochol PF and Carbachol PF in three new regions: Greater China, South Korea, and select Southeast Asian territories.